-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
quote:Originally posted by Intimatrader: People like to pick stocks that are already moning up ...as gappers
The real skill comes in picking one that is at bottom ... With no momemtum tell tale signs ...only good solid DD.
I pick AWBV .......& ......JMCP
You can't get any more bottom then your picks keep up that "good" DD
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
quote: People like to pick stocks that are already moning up ...as gappers
The real skill comes in picking one that is at bottom ... With no momemtum tell tale signs ...only good solid DD.
I pick AWBV .......& ......JMCP
You can't get any more bottom then your picks keep up that "good" DD
lol
I'm going with XKEM since it had another strong close! Break of $.03 tomorrow would be sweeeeet!
Posts: 3026 | From: Chicago | Registered: Oct 2005
| IP: Logged |
XKEM... Careful...RSI over 70% and may gap and then shake hard if no PR pre-market...If your just getting in at the open check out the charts first and plan your play..IMHO
Posts: 2660 | From: Pennyland USA | Registered: Jun 2004
| IP: Logged |
-------------------- "I will smack you in the mouth, I'm Neil Diamond"- Will Ferrell Posts: 4190 | From: Rhode Island | Registered: Mar 2006
| IP: Logged |
-------------------- A million unemployed comedians and you are trying to be funny, have you no shame? Posts: 128 | From: Here | Registered: Apr 2006
| IP: Logged |
posted
XKEM, ONLY at 70% that means it still has 20% for RSI to be considered "becareful". And even than it might just consolidate 10% to 20% than gap up hard again.
Posts: 1227 | Registered: Feb 2006
| IP: Logged |
quote:Originally posted by tonicma: XKEM, ONLY at 70% that means it still has 20% for RSI to be considered "becareful". And even than it might just consolidate 10% to 20% than gap up hard again.
Very true...If it gaps at open that RSI may hit the "becareful" target in the first 15-30 mins... Your correct also that it may only shake up to 10% to 20% to backfill....It also may behave differently...Be nice if the PR came out pre-market...
Posts: 2660 | From: Pennyland USA | Registered: Jun 2004
| IP: Logged |
posted
Your wish has come truw. There is huge PR this morning just after you said it would be nice if the PR came out pre-market...
Posts: 1134 | Registered: Apr 2003
| IP: Logged |
Created to Protect Against Age-Related Degeneration
TORONTO, Jun 06, 2006 (MARKET WIRE via COMTEX) -- Anti Aging Medical Group Corp. (PINKSHEETS: AAGM), a specialty pharmaceutical company focused on developing, acquiring and commercializing innovative and scientifically proven products that offer both health maintenance and appearance enhancing benefits, announces the North American marketing rights for their brand new product, CoQ10 ER a dietary supplement created to protect against age-related degeneration. The CoQ10 ER product will be licensed from AlphaRx Inc. (OTCBB: ALRX). CoQ10 has been previously identified as a natural anti-oxidant with potential use as a dietary supplement to protect against age-related degeneration and as an adjuvant vitamin to prevent or treat many disease states. Supplementary Coenzyme Q10 has reportedly shown beneficial influences in a variety of conditions or diseases, including: congestive heart failure, angina, periodontal disease, certain blood circulation diseases, impaired memory, fatigue, irregular heartbeat, high blood pressure, immune system impairment, and the aging process.
"Here at AAGM, we feel that this new product will fit perfectly into what the Anti Aging community is looking for. We are in the day and age where vitamins and nutritional supplements can make a difference in people's lives. CoQ10 offers the nutritional benefits of a multivitamin along with the pep and energy of the popular non-caffeinated energy drinks." (Rita Sung, CEO AAGM)
Packaging and selling this new product will strengthen AAGM's position in the ever growing world of vitamin supplements and also allow penetration into various markets around the world. In addition to this, the C0Q10ER will allow AAGM to focus and capitalize on more than one product.
"We have the products and now we will focus on creating the brand under which these products will be marketed and sold under." (Rita Sung, CEO)
CoQ10 ER once-a-day tablet is scientifically formulated using a proprietary bioadhesive colloidal dispersion drug delivery technology to enhance target site delivery, biological activity and oral bioavailability. CoQ10 ER is delivered to the human cells using a proprietary S.E.C.R.E.T. (Self Emulsifying Controlled Release Tablet) drug delivery process which completely disperses CoQ10 ER into sub-micron oil droplets in the GI tract. The average size of these oil droplets is less than 100 nanometer. These oil droplets can easily penetrate the bilayer of human cells and deliver CoQ10 where it is needed most.
Another scientific breakthrough in CoQ10 ER is its ability to maintain a steady supply of CoQ10 in the GI tract, keeping the health-supporting properties of CoQ10 in the body for a longer period. This is achieved by using SECRET's precision drug delivery matrix which allows CoQ10 ER's molecular composition to precisely release CoQ10 over a specific time interval.
CoQ10 ER contains a truly water dispersible form of natural source Vitamin E. Vitamin E plays a critical role in the body by protecting LDL and cell membranes from oxidation damage. Several laboratory and clinical studies have shown the importance of vitamin E in supporting good cardiovascular health and a strong immune system in the elderly. The Vitamin E in CoQ10 ER is delivered to the human cells under the same SECRET mechanism. Therefore, it is much more readily absorbed by the cell membranes and last longer in the body than other forms of Vitamin E currently available in the market.
About Anti Aging Medical Group Corp.
We are a specialty pharmaceutical company focused on developing, acquiring and commercializing innovative and scientifically proven products that offer both health maintenance and appearance enhancing benefits to all of us. We here at Anti-Aging Medical Group Corporation call this Nutraceuticals and Cosmeceuticals. Nutraceuticals are products that have multiple benefits in terms of revitalization for, vision, prostate, bone and joint care as well as memory improvement. At Anti-Aging Medical Group Corporation, we are developing a drug delivery based, proprietary, non-prescription topical and oral product line which are fast becoming the industry's leader in the treatment of age resistance. Cosmeceuticals -- are skin care products which are specifically designed to enhance the appearance of your skin while catering to its needs.
Anti-Aging Medical Group Corporation is developing a drug delivery based, proprietary skin care product line which fall under our Cosmeceuticals product line. Cosmeceuticals will not only reduce the signs of aging but they also provide significant skin care benefits. They serve to enhance skin appearance and reduce signs of aging. For more information about us please visit our website at www.anti-agingmedical.net.
This news release contains forward-looking statements. These statements describe management's current beliefs and expectations concerning the future of Anti Aging Medical Corp. These forward-looking statements are identified by using words such as "expect," "believe," and "should." Although the beliefs and expectations mentioned in this release are reasonable, the Company's operations involve a number of risks and uncertainties. Therefore, these statements may turn out not to be true.
The Company will not update forward-looking statements in this news release to reflect actual results, changes in assumptions, or changes in other factors affecting such forward-looking information.
FORWARD-LOOKING STATEMENTS:
This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.
Note: The FDA has not evaluated these statements. This statement is not intended to diagnose, treat, cure of prevent disease.
Copyright 2006 Market Wire, All rights reserved.
Distributed by Filing Services Canada and retransmitted by Market Wire
SUBJECT CODE: Pharmaceuticals and Biotech:Biotech Pharmaceuticals and Biotech:Drugs Pharmaceuticals and Biotech:Equipment and Supplies Pharmaceuticals and Biotech:Trials
Search for Dun & Bradstreet reports on this company.
Posts: 112 | From: Tucson, Az. | Registered: Apr 2006
| IP: Logged |
posted
crdm . this stock i see touching a new high in the coming days .
when i spoke to the company management . the product is ready for marketing and they should come out with some huge contracts .
Posts: 417 | From: grand cayman | Registered: May 2006
| IP: Logged |
-------------------- Making it a little at a time....Now is the time to determine if you are a man or a mouse. Posts: 1543 | From: Ogilvie, MN, US | Registered: Apr 2004
| IP: Logged |
posted
hopefully the market in general, but i doubt it.... look at it this way, it s time to buy
Posts: 27 | From: florida | Registered: Mar 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
